Log In
BCIQ
Print this Print this
 

TZP-201

  Manage Alerts
Collapse Summary General Information
Company Ocera Therapeutics Inc.
DescriptionMotilin receptor antagonist
Molecular Target Motilin receptor
Mechanism of ActionMotilin receptor antagonist
Therapeutic ModalityMacrocycle
Latest Stage of DevelopmentPreclinical
Standard IndicationDiarrhea (non-infectious)
Indication DetailsTreat chemotherapy-induced diarrhea (CID)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today